14158 Results (Page 548 of 567)
All Market Research Reports
UAE Bio-Implant Market Analysis
The UAE Bio-implant Market was valued at $325 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $518.5 Mn by 2030. The UAE Bio-implant Market is growing due to the Growing Aging Population, Government Initiatives and Healthcare Infrastructure Development, and Rising Chronic Disease Prevalence. The market is primarily dominated by players such as ProvenMed, Global Med Hub FZ LLC, Sinterex, ThermoMind, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Vietnam Lipid Disorder Therapeutics Market Analysis
The Vietnam Lipid Disorder Therapeutics Market was valued at $28.3 Mn in 2023 and is predicted to grow at a CAGR of 14.13% from 2023 to 2030, to $71.3 Mn by 2030. Vietnam Lipid Disorder Therapeutics Market is growing due to the Rising Prevalence of Non-Communicable Diseases, Growing Awareness and Focus on Chronic Disease Management, and Increasing Healthcare Expenditure. The industry is primarily dominated by players such as Boehringer Ingelheim, Sanofi, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
France Actinic Keratosis Therapeutic Market Analysis
The France Actinic Keratosis Therapeutic Market is projected to grow at a CAGR of 3.9%, increasing from $187 Mn in 2022 to reach $254 Mn by the year 2030. Actinic Keratosis is becoming more common, and there are a number of reasons for this, such as more awareness and changing lifestyles, improved diagnostic tools, prolonged exposure and aging populations, and increased focus on skin health. The key players in the French market include Galderma, Almirall, Sun Pharma, Novartis, Pierre Fabre Laboratories, LFB Biotechnologies etc.
China Constipation Therapeutics Market Analysis
China Constipation Therapeutics Market was valued at $1463 Mn in 2022 and is estimated to reach $2708 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include Pfizer, AstraZeneca, Johnson & Johnson, GlaxoSmithKline, Merck & Co., Novartis, Sanofi, Takeda, Shanghai Fosun Pharmaceutical, and Beijing Tongrentang.
Malaysia Mental Health Apps Market Analysis
The Malaysia Mental Health Apps Market was valued at $9.97 Mn in 2023 and is predicted to grow at a CAGR of 15.4% from 2023 to 2030, to $27.17 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, a shortage of professionals, and government support. The industry is primarily dominated by players such as HeadSpace, Calm, Happify, and PlusVibes among others.
India CT Scan Market Analysis
India CT Scan Market was valued at $83.84 Mn in 2023 and is predicted to grow at a CAGR of 10.87% from 2023 to 2030, to $172.64 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, growing population, and increasing healthcare expenditure. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and Koninklijke Philips, among others.
Malaysia Bio-Implant Market Analysis
The Malaysia Bio-implant Market was valued at $104.5 Mn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $158.2 Mn by 2030. The Malaysia Bio-implant Market is growing due to like Rising Prevalence of Chronic Diseases, Increasing Healthcare Expenditure, and Growing Medical Tourism Industry. The market is primarily dominated by players such as APEX Healthcare Berhad, Hartalega Holdings Berhad, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Kenya Lipid Disorder Therapeutics Market Analysis
Kenya Lipid Disorder Therapeutics Market was valued at $7.1 Mn in 2023 and is predicted to grow at a CAGR of 13.73% from 2023 to 2030, to $17.4 Mn by 2030. Kenya Lipid Disorder Therapeutics Market is growing due to Increasing Healthcare Expenditure, the Rising Prevalence of Cardiovascular Diseases (CVDs), Public Awareness, and Early Intervention. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Germany Actinic Keratosis Therapeutic Market Analysis
The Germany Actinic Keratosis Therapeutic Market is expected to grow at a CAGR of 3.10%, rising from $249 Mn in the year 2022 reaching $318 Mn by the year 2030. The rising incidence of actinic keratosis, improvements in treatment options, rising public awareness and screening programs, encouraging government initiatives, technological advancements, an aging population, market competition, and patient preferences are the factors driving the Germany Actinic Keratosis Therapeutic Market. The key players in the Germany Actinic Keratosis Therapeutic Market include Bayer, Galderma, Pierre Fabre, Chemiplastics, Oncopharma, Aclaris Therapeutics, Varens, Photocure, Meda Pharma etc.
Egypt Constipation Therapeutics Market Analysis
Egypt Constipation Therapeutics Market was valued at $51 Mn in 2022 and is estimated to reach $94 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The global growth of the constipation therapeutics market is driven by factors such as aging, sedentary lifestyles, and unhealthy dietary habits. The increasing elderly population, susceptible to chronic conditions, notably contributes to this expansion. Major players in this sector comprise Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Merck & Co., Novartis, and Pfizer.
Philippines Mental Health Apps Market Analysis
The Philippines Mental Health Apps Market was valued at $13.64 Mn in 2023 and is predicted to grow at a CAGR of 15.7% from 2023 to 2030, to $37.86 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, a shortage of professionals, and government support. The industry is primarily dominated by players such as Calm, Happify, Ten Percent Happier, and Lusog-Isip among others.
Canada Herbal Supplements Market Report
The Canada Herbal Supplements Market was valued at $420.80 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $641.13 Mn by 2030. The key drivers of this industry include growing health awareness, preference for natural products, and aging population. The industry is primarily dominated by players such as Nature’s Way, New Chapter, New Roots Herbal, Botanica Health, and Herbalife among others.
Vietnam Bio-Implant Market Analysis
The Vietnam Bio-implant Market was valued at $325 Mn in 2023 and is predicted to grow at a CAGR of 6.13% from 2023 to 2030, to 492.9 Mn by 2030. The Vietnam Bio-implant Market is growing due to like Increasing Disposable Income and Health Awareness, Growing Aging Population, Government Initiatives and Support. The market is primarily dominated by players such as Orthopaedic International, OrthoMed, Medline Vietnam, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
South Africa Lipid Disorder Therapeutics Market Analysis
South Africa Lipid Disorder Therapeutics Market was valued at $252.5 Mn in 2023 and is predicted to grow at a CAGR of 13.63% from 2023 to 2030, to $617.6 Mn by 2030. South Africa Lipid Disorder Therapeutics Market is growing due to Advancements in Therapeutics, Increasing Healthcare Expenditure, and the Rising Prevalence of Cardiovascular Diseases (CVDs). The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
France Constipation Therapeutics Market Analysis
France Constipation Therapeutics Market was valued at $501 Mn in 2022 and is estimated to reach $768 Mn in 2030, exhibiting a CAGR of 5.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by rising global rates of constipation associated with factors like aging, sedentary lifestyles, and poor dietary habits, as well as the expanding elderly population, which is particularly prone to chronic conditions. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Ipsen Pharma, Johnson & Johnson, Norgine Pharmaceuticals, Pierre Fabre Médicament, Recordati and Sanofi.
Singapore Mental Health Apps Market Analysis
The Singapore Mental Health Apps Market was valued at $7.44 Mn in 2023 and is predicted to grow at a CAGR of 15.8% from 2023 to 2030, to $20.77 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, rising awareness, and government support. The industry is primarily dominated by players such as Calm, Happify, Headspace, and MindFi among others.
US Herbal Supplements Market Report
The US Herbal Supplements Market was valued at $2209.20 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $2946.52 Mn by 2030. The key drivers of this industry include increasing health consciousness, rising stress levels, and an aging population. The industry is primarily dominated by players such as Amway, Nature Made, Youtheory, Natrol, and Vitafusion among others.
Philippines Bio-Implant Market Analysis
The Philippines Bio-implant Market was valued at $143 Mn in 2023 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to 220.8 Mn by 2030. The Philippines Bio-implant Market is growing due to like the Aging Population, Growing Medical Tourism Industry, and Government Healthcare Initiatives. The market is primarily dominated by players such as Orthopaedic International, OrthoMed, Medline Philippines, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
India Lipid Disorder Therapeutics Market Analysis
The India Lipid Disorder Therapeutics Market was valued at $151.5 Mn in 2023 and is predicted to grow at a CAGR of 12.88% from 2023 to 2030, to $353.8 Mn by 2030. India Lipid Disorder Therapeutics Market is growing due to the Prevalence of cardiovascular diseases, Consumer preference for over-the-counter (OTC) drugs, Advancements in Therapeutics, and Growing Healthcare Expenditure and Infrastructure. The industry is primarily dominated by players such as Sun Pharmaceutical Industries Ltd., Cipla, Lupin, Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie, Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Japan Castrate Resistant Prostate Cancer Therapeutics Market Analysis
Japan Castrate Resistant Prostate Cancer Therapeutics Market valued at $634 Mn in 2022, projected to reach $1139 Mn by 2030 with a 7.6% CAGR. The key driver of the market in Japan is the significant surge in the aging population, particularly those at higher risk of age-related cancers, coupled with increased diagnostics, screening, and a growing awareness of the disease and treatment options. The Japan Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Sanofi, Bayer, Astellas, AbbVie, Eisai, Novartis, AstraZeneca, Bristol-Myers Squibb, etc, among various others.
Germany Constipation Therapeutics Market Analysis
Germany Constipation Therapeutics Market was valued at $666 Mn in 2022 and is estimated to reach $962 Mn in 2030, exhibiting a CAGR of 4.7% during the forecast period. The constipation therapeutics market is experiencing growth driven by rising global rates of constipation associated with factors like aging, sedentary lifestyles, and poor dietary habits, as well as the expanding elderly population, which is particularly prone to chronic conditions. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Ipsen Pharma, Johnson & Johnson, Norgine Pharmaceuticals, Pierre Fabre Médicament, Recordati, and Sanofi.
Vietnam Mental Health Apps Market Analysis
The Vietnam Mental Health Apps Market was valued at $31 Mn in 2023 and is predicted to grow at a CAGR of 15.43% from 2023 to 2030, to $84.64 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, rising awareness, and rising interest in preventive care. The industry is primarily dominated by players such as Calm, Happify, Headspace, and Wysa among others.
Saudi Arabia Herbal Supplements Market Report
The Saudi Arabia Herbal Supplements Market was valued at $89.42 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $150.30 Mn by 2030. The key drivers of this industry include health consciousness, preventive healthcare trends, and the young population. The industry is primarily dominated by players such as Himalaya Wellness, NOW Foods, Botanic Supplements, and Dabur among others.
Egypt Bio-Implant Market Analysis
The Egypt Bio-implant Market was valued at $182 Mn in 2023 and is predicted to grow at a CAGR of 7.4/% from 2023 to 2030, to $300 Mn by 2030. The Egypt Bio-implant Market is growing due to like Increasing Chronic Disease Prevalence, Rising Disposable Income and Healthcare Spending, and Technological Innovations in Implant Materials. The market is primarily dominated by players such as Alexandria Advanced Technologies, Medica Egypt, Misr Medicare, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Kenya Actinic Keratosis Therapeutic Market Analysis
Kenya Actinic Keratosis Therapeutic Market is expected to expand at a CAGR of 6% from $5 Mn in 2022 to $8 Mn by 2030. The market is expected to grow as a result of rising prevalence combined with specific environmental variables, a shifting economic landscape, rising disposable incomes, and more access to healthcare services in Kenya. International and local players Galderma, Bayer, Novartis, Mediheal Pharmaceuticals, Mifa, Kepharth etc, contribute to the therapeutic management of Actinic Keratosis
